InsiderChief Executive Officer
Neil Kumar Insider Trading Activity
Every SEC Form 4 transaction reported by Neil Kumar, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Is Neil Kumar buying or selling?
Neil Kumar reported 3 open-market buys ($72.0M) and 52 sells ($149.5M) across 55 Form 4 filings at 2 companies — a net selling position of $77.5M.
Source: SEC EDGAR Form 4
What stands out
- Neil Kumar has reported Form 4 transactions at 2 companies; the most active, BridgeBio Pharma, Inc. (BBIO), accounts for 52 of 55 filings (95%).
- The most recent Form 4 was accepted on Sep 21, 2026 (27 days ago).
- In the last 12 months: no open-market purchases and 14 sales ($57.2M).
- The largest open-market sale in the last 12 months was $6.0M of BridgeBio Pharma, Inc. (BBIO) on Jan 13, 2026. SEC ↗
Key Statistics (as of Sep 21, 2026)
Total Form 4 filings
55
SEC EDGAR
Companies
2
Buys (3)
$72.0M
Sells (52)
$149.5M
Insider sentiment
Net sellingNet insider flow of $77.5M in net selling, filed between Jun 22, 2018 – Sep 21, 2026.
Companies Neil Kumar files for
Recent Neil Kumar transactions
| Date | Ticker | Role | Type | Shares | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 21, 2026 | BBIO | Chief Executive Officer | Sale | 10.0K | $690.8K | SEC ↗ |
| Aug 20, 2026 | BBIO | Chief Executive Officer | Sale | 45.0K | $3.7M | SEC ↗ |
| Jun 8, 2026 | BBIO | Chief Executive Officer | Sale | 80.0K | $5.4M | SEC ↗ |
| May 26, 2026 | BBIO | Chief Executive Officer | Sale | 26.1K | $1.8M | SEC ↗ |
| May 11, 2026 | BBIO | Chief Executive Officer | Sale | 80.0K | $5.4M | SEC ↗ |
| Apr 13, 2026 | BBIO | Chief Executive Officer | Sale | 80.0K | $6.0M | SEC ↗ |
| Mar 16, 2026 | BBIO | Chief Executive Officer | Sale | 80.0K | $5.5M | SEC ↗ |
| Feb 23, 2026 | BBIO | Chief Executive Officer | Sale | 28.1K | $2.0M | SEC ↗ |
| Feb 12, 2026 | BBIO | Chief Executive Officer | Sale | 80.0K | $5.7M | SEC ↗ |
| Jan 13, 2026 | BBIO | Chief Executive Officer | Sale | 80.0K | $6.0M | SEC ↗ |
| Dec 16, 2025 | BBIO | Chief Executive Officer | Sale | 30.0K | $2.2M | SEC ↗ |
| Dec 8, 2025 | BBIO | Chief Executive Officer | Sale | 80.0K | $5.9M | SEC ↗ |
| Nov 24, 2025 | BBIO | Chief Executive Officer | Sale | 26.2K | $1.7M | SEC ↗ |
| Nov 10, 2025 | BBIO | Chief Executive Officer | Sale | 80.0K | $5.0M | SEC ↗ |
| Oct 10, 2025 | BBIO | Chief Executive Officer | Sale | 80.0K | $4.4M | SEC ↗ |
| Sep 8, 2025 | BBIO | Chief Executive Officer | Sale | 80.0K | $4.2M | SEC ↗ |
| Aug 22, 2025 | BBIO | Chief Executive Officer | Sale | 26.2K | $1.3M | SEC ↗ |
| Aug 11, 2025 | BBIO | Chief Executive Officer | Sale | 80.0K | $3.7M | SEC ↗ |
| Jul 3, 2025 | BBIO | Chief Executive Officer | Sale | 80.0K | $3.4M | SEC ↗ |
| May 20, 2025 | BBIO | Chief Executive Officer | Sale | 101.2K | $3.4M | SEC ↗ |
| Apr 24, 2025 | BBIO | Chief Executive Officer | Sale | 75.0K | $2.6M | SEC ↗ |
| Mar 27, 2025 | BBIO | Chief Executive Officer | Sale | 75.0K | $2.8M | SEC ↗ |
| Feb 27, 2025 | BBIO | Chief Executive Officer | Sale | 75.0K | $2.5M | SEC ↗ |
| Feb 20, 2025 | BBIO | Chief Executive Officer | Sale | 31.5K | $1.1M | SEC ↗ |
| Jan 30, 2025 | BBIO | Chief Executive Officer | Sale | 600.0K | $21.8M | SEC ↗ |
Showing the 25 most recent filings of 55. Screen every filing.
Neil Kumar insider trading FAQ
Is Neil Kumar buying or selling?
Across 55 SEC Form 4 filings, Neil Kumar reported 3 open-market purchases totaling $72.0M and 52 sales totaling $149.5M — a net selling position of $77.5M.
Which companies does Neil Kumar file Form 4s for?
Neil Kumar has reported insider transactions at 2 companies, most often BridgeBio Pharma, Inc. (BBIO), Eidos Therapeutics, Inc. (EIDX).
How far back does Neil Kumar's filing history go?
Trabud holds Neil Kumar's SEC Form 4 filings from Jun 22, 2018 – Sep 21, 2026, sourced directly from SEC EDGAR.
Where does Trabud get Neil Kumar's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Neil Kumar and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener